1997
Design and Baseline Participant Characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: A Prospective Cohort Study of Human Immunodeficiency Virus Infection in US Women
Smith D, Warren D, Vlahov D, Schuman P, Stein M, Greenberg B, Holmberg S, Group F. Design and Baseline Participant Characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: A Prospective Cohort Study of Human Immunodeficiency Virus Infection in US Women. American Journal Of Epidemiology 1997, 146: 459-469. PMID: 9290506, DOI: 10.1093/oxfordjournals.aje.a009299.Peer-Reviewed Original ResearchConceptsUS womenHuman immunodeficiency virus (HIV) infectionPublic Health Service agenciesImmunodeficiency virus infectionProspective cohort studyInjection drug useHIV-infected womenBaseline participant characteristicsInpatient medical recordsHealth service agenciesSexual risk behaviorsUninfected womenHIV cohortCohort studyInfected womenHIV infectionPhysical examinationMedical recordsHIV epidemicLongitudinal cohortVirus infectionCare settingsHigh riskDrug useRisk behaviors
1995
Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial
Harrison K, Vlahov D, Jones K, Charron K, Clements M. Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 386-390. PMID: 7552502, DOI: 10.1097/00042560-199511000-00012.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS VaccinesClinical Trials as TopicComprehensionConsent FormsDouble-Blind MethodEducational StatusEligibility DeterminationFemaleHIV InfectionsHumansInformed ConsentMaleMiddle AgedPatient SelectionResearch DesignResearch SubjectsSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsInjection drug usersHIV vaccine trialsVaccine trialsDrug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionPhase II trialInformed consent procedureConsent proceduresII trialVirus infectionHigh riskMedical reasonsMedical eligibilityTrialsConsent processEnrollmentFollowInfectionFalse testVisits
1994
HIV seroconversion studies among intravenous drug users
Vlahov D. HIV seroconversion studies among intravenous drug users. AIDS 1994, 8: 263-266. PMID: 8043233, DOI: 10.1097/00002030-199402000-00016.Peer-Reviewed Original Research
1987
The infection control practitioner as investigator of clinical phenomena
Larson E, Bolyard E, Vlahov D. The infection control practitioner as investigator of clinical phenomena. American Journal Of Infection Control 1987, 15: 215-220. PMID: 3674539, DOI: 10.1016/0196-6553(87)90099-x.Peer-Reviewed Original Research